W. Krischke

发表

Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU.

S. Seeber, N. Niederle, C. Schmidt, 1982, Cancer treatment reviews.

[Distribution of stained ascites tumor cells in the organism after intravenous or intracardiac injection in the mouse. A contribution to experimental metastasis].

W. Krischke, 1960, Acta biologica et medica Germanica.

Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors.

S. Seeber, M. Scheulen, N. Niederle, 1982, Cancer treatment reviews.

Is there any clinical relevance of serial determinations of serum carcinoembryonic antigen in small cell lung cancer patients?

N. Niederle, H. Hirche, J. Schütte, 1988, Cancer.

Tumor Inhibiting [1,2‐Bis(fluorophenyl)ethylenediamine]platinum(II) Complexes Part II: Biological Evaluation ‐in vitro Studies on the P 388 D1 Leukemia Cell Line

J. Engel, S. Seeber, R. Gust, 1990, Archiv der Pharmazie.

The transmission of the virus of myeloid leukaemia of mice by the milk.

A. Graffi, W. Krischke, 1963, Acta - Unio Internationalis Contra Cancrum.

Tumor inhibiting [1,2-bis(fluorophenylethylenediamine]platinum-(II) complexes. Part I: synthesis

J. Engel, R. Gust, H. Reile, 1989 .

Vindesine/Cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung

S. Seeber, N. Niederle, C. Schmidt, 1984, Klinische Wochenschrift.

4′-Epi-doxorubicin — A clinical phase-II trial in solid tumors

S. Seeber, N. Niederle, C. Schmidt, 2004, Journal of Cancer Research and Clinical Oncology.

A simple method of delayed processing of tumor tissue in a soft agar clonogenic assay

Martin R. Schneider, R. Hartmann, H. Schönenberger, 2004, Journal of Cancer Research and Clinical Oncology.